Nov 7 (Reuters) - Geron Corp GERN.O:
ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN GERON’S RYTELO FOR $125 MILLION
ROYALTY PHARMA PLC -DEAL INCREASES SYNTHETIC ROYALTY FUNDING TO $925 MILLION IN 2024
Source text: ID:nGNXs5fdM
Further company coverage: GERN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.